Xenetic Biosciences (XBIO) Earnings Date, Estimates & Call Transcripts $2.89 +0.07 (+2.34%) Closing price 08/22/2025 03:19 PM EasternExtended Trading$2.91 +0.02 (+0.83%) As of 08/22/2025 06:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsOwnershipSEC FilingsShort InterestTrendsBuy This Stock Xenetic Biosciences Earnings Summary Xenetic Biosciences released Q2 2025 earnings on August 12, 2025, reporting an EPS of -$0.45, which beat analysts' consensus estimates of -$0.64 by $0.19. Quarterly revenue was reported to be $0.59 million, above the consensus estimate of $0.48 million. With a trailing EPS of -$2.00, Xenetic Biosciences' earnings are expected to grow next year, from ($1.01) to ($0.66) per share. Upcoming Q3 Earnings DateNov. 11Before Market OpensEstimatedConsensus EPS (Aug. 12) -$0.64 Actual EPS (Aug. 12) -$0.45 Beat By $0.19 Actual Revenue (Aug. 12) $0.59MQ2 2025 Earnings ResourcesQ2 2025 Earnings Report Quarterly Report (10-Q) Press Release (8-K)XBIO Upcoming EarningsXenetic Biosciences' next earnings date is estimated for Tuesday, November 11, 2025, based on past reporting schedules. Powered by Get Xenetic Biosciences Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Xenetic Biosciences and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataXBIO Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.XBIO Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Xenetic Biosciences Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.72-$0.72-$0.72Q2 20251-$0.64-$0.64-$0.64Q3 20251-$0.49-$0.49-$0.49Q4 20251-$0.52-$0.52-$0.52 Xenetic Biosciences Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 11/11/2025(Estimated)--------8/12/2025Q2 2025-$0.64-$0.45+$0.19-$0.45$0.48M$0.59M5/13/2025Q1 2025-$0.72-$0.59+$0.13-$0.59$0.52M$0.59M3/18/2025Q4 2024-$0.20-$0.68 -$0.48-$0.68$0.18M$0.65M11/12/2024--$0.14-$0.28 -$0.14-$0.28$0.75M$0.61M8/13/2024--$0.83-$0.83--$0.83$0.54M$0.73M5/9/2024Q1 2024-$0.79-$0.78+$0.01-$0.78$0.65M$0.51M3/21/2024Q4 2023-$0.87-$0.77+$0.10-$0.77$0.68M$0.67M11/10/2023Q3 2023-$1.12-$0.69+$0.43-$0.69$0.46M$0.61M Xenetic Biosciences Earnings - Frequently Asked Questions When is Xenetic Biosciences' earnings date? Xenetic Biosciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 11th, 2025 based off last year's report dates. Learn more on XBIO's earnings history. Did Xenetic Biosciences beat their earnings estimates last quarter? In the previous quarter, Xenetic Biosciences (NASDAQ:XBIO) reported ($0.45) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.64) by $0.19. Learn more on analysts' earnings estimate vs. XBIO's actual earnings. How much revenue does Xenetic Biosciences generate each year? Xenetic Biosciences (NASDAQ:XBIO) has a recorded annual revenue of $2.50 million. How much profit does Xenetic Biosciences generate each year? Xenetic Biosciences (NASDAQ:XBIO) has a recorded net income of -$3.96 million. XBIO has generated -$2.00 earnings per share over the last four quarters. What is Xenetic Biosciences' EPS forecast for next year? Xenetic Biosciences' earnings are expected to grow from ($1.01) per share to ($0.66) per share in the next year. More Earnings Resources from MarketBeat Related Companies X4 Pharmaceuticals Earnings Results Pulmatrix Earnings Results Hoth Therapeutics Earnings Results Lexaria Bioscience Earnings Results Adaptimmune Therapeutics Earnings Results Synlogic Earnings Results Edesa Biotech Earnings Results Lipocine Earnings Results BioLineRx Earnings Results Mannatech Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles After Earnings Miss, Walmart Is Still a Top Consumer Staples PlayRoyal Caribbean Earnings Beat Fuels Strong 2025 OutlookDLocal Stock Soars 43% After Earnings Beat and Raised GuidanceGreen Dot's 30% Rally: Turnaround Takes Off on Explosive EarningsElbit Systems Jumps on Record Earnings and a $1.6B ContractBrinker Serves Up Earnings Beat, Sidesteps Cost PressuresWhy BigBear.ai Stock's Dip on Earnings Can Be an Opportunity This page (NASDAQ:XBIO) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Xenetic Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Xenetic Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access